DHILLON PUNIT
SEC insider (Form 3/4/5 filer). CIK 0001425052. Chief Executive Officer at Skye Bioscience, Inc. (SKYE). 20 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in SAN DIEGO, CA.
Companies DHILLON PUNIT has filed insider reports for
- Skye Bioscience, Inc. (SKYE): Director, Officer, Chief Executive Officer
DHILLON PUNIT
CIK: 0001425052
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Skye Bioscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Aug 7, 2026SKYE
Skye Bioscience, Inc.
AwardDirect1.1M shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
650K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
DispositionDirectStock Option (Right to Buy)
125K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
9K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
DispositionDirectStock Option (Right to Buy)
9K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
21.6K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
DispositionDirectStock Option (Right to Buy)
21.6K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
250K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
DispositionDirectStock Option (Right to Buy)
250K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
36K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 | SKYE Skye Bioscience, Inc. | Award | 1,090,000 | - | $0 | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 650,000 | - | - | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Disposition Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 9,013 | - | - | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Disposition Stock Option (Right to Buy) | 9,013 | - | - | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 21,586 | - | - | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Disposition Stock Option (Right to Buy) | 21,586 | - | - | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Disposition Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 36,000 | - | - | Direct |
1-10 of 20 transactions